# UBS Group AG: overview

UBS · NYSE · CIK 1610520 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/ubs.md) · [Financials](/companies/ubs/financials.md) · [Filings](/companies/ubs/filings.md) · [Insiders](/companies/ubs/insiders.md)

Revenue is not reported in this company’s XBRL financial statements.

## Last eight quarters

Not reported.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $bn | [35.4](/filings/0001610520-22-000028.md) | not reported | not reported | not reported | not reported |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | [21.2%](/filings/0001610520-24-000041.md) | not reported | not reported | not reported | not reported |
| Diluted EPS | $ per share | [2.06](/filings/0001610520-24-000041.md) | [2.25](/filings/0001610520-25-000023.md) | [8.30](/filings/0001610520-26-000023.md) | [1.52](/filings/0001610520-26-000023.md) | [2.36](/filings/0001610520-26-000023.md) |
| Free cash flow | $bn | not reported | not reported | not reported | not reported | not reported |

- Revenue. XBRL Revenue: ifrs-full:Revenue.
- Gross margin (gross profit / revenue). XBRL Revenue: ifrs-full:Revenue.
- Operating margin (operating income / revenue). XBRL Revenue: ifrs-full:Revenue.
- Net margin (net income / revenue). XBRL Net income: ifrs-full:ProfitLoss; Revenue: ifrs-full:Revenue.
- Diluted EPS. XBRL Diluted EPS: ifrs-full:DilutedEarningsLossPerShare.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: ifrs-full:CashFlowsFromUsedInOperatingActivities.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/ubs/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

None of the funds in coverage reports a position in its latest 13F.

## Recent filings

[All 491 filings](/companies/ubs/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-29 | 06:29 ET | [6-K](/filings/0001610520-26-000113.md) | Report of a foreign private issuer, period 2026-09-30 | 0001610520-26-000113 |
| 2026-10-28 | 06:25 ET | [6-K](/filings/0001610520-26-000111.md) | Report of a foreign private issuer, period 2026-09-30 | 0001610520-26-000111 |
| 2026-10-28 | 06:18 ET | [6-K](/filings/0001610520-26-000109.md) | Report of a foreign private issuer, period 2026-09-30 | 0001610520-26-000109 |
| 2026-10-28 | 06:17 ET | [6-K](/filings/0001610520-26-000108.md) | Report of a foreign private issuer, period 2026-09-30 | 0001610520-26-000108 |
| 2026-10-28 | 06:12 ET | [6-K](/filings/0001610520-26-000106.md) | Report of a foreign private issuer, period 2026-09-30 | 0001610520-26-000106 |
| 2026-07-29 | 06:58 ET | [6-K](/filings/0001610520-26-000086.md) | Report of a foreign private issuer, period 2026-07-29 | 0001610520-26-000086 |
| 2026-05-05 | 06:18 ET | [6-K](/filings/0001610520-26-000056.md) | Report of a foreign private issuer, period 2026-05-05 | 0001610520-26-000056 |
| 2026-04-29 | 06:52 ET | [6-K](/filings/0001610520-26-000047.md) | Report of a foreign private issuer, period 2026-03-31 | 0001610520-26-000047 |
| 2026-04-29 | 06:50 ET | [6-K](/filings/0001610520-26-000046.md) | Report of a foreign private issuer, period 2026-03-31 | 0001610520-26-000046 |
| 2026-03-16 | 06:14 ET | [6-K](/filings/0001610520-26-000039.md) | Report of a foreign private issuer, period 2026-03-16 | 0001610520-26-000039 |

## Latest annual report

[Form 20-F for the fiscal year ended Dec 31, 2025](/filings/0001610520-26-000023.md), filed Mar 9, 2026.

## Forecast league

Not in this season’s league. [This season’s league](/leagues.md)

## About the filer

- CIK: 1610520
- Tickers: UBS
- Exchange: NYSE
- SIC code: 6021 National Commercial Banks
- State of incorporation: V8
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Nov 10, 2026, 22:05 ET. No prices; not investment advice.
